Global Cholesterol and Other Cardiovascular Testing Market to Reach 2.3 Billion Units by 2015, According to a New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on Cholesterol and Other Cardiovascular Testing markets. The global market for Cholesterol and Other Cardiovascular Testing is forecast to cross 2.3 billion units by the year 2015. Key factors driving market growth include aging population, increasing incidence of cardiovascular diseases, and growing awareness among people about the significance of reducing the unhealthy cholesterol levels.

Cholesterol and Other Cardiovascular Testing: A Global Strategic Business Report

Global market for cholesterol and other cardiovascular testing market was fairly immune to the recent slump in the global economy and grew healthily during 2008-2009. Cholesterol testing is gaining prominence as the basic and most important marker for assessing the risk of heart disease, the number one killer the world over. Aging baby boomers, more susceptible to heart diseases, continue to drive the market for cholesterol and other cardiovascular testing. Further, several state cardiovascular health programs administered and funded by the Centers for Disease Control and Prevention help in increasing awareness among people about the significance of reducing the unhealthy cholesterol levels to control heart disease. Greater awareness about the risks of heart attack and cholesterol increased the need among several individuals to control their cholesterol levels, which further bolstered the demand for cholesterol and other cardiovascular testing.

Asia-Pacific represents the largest region for cholesterol and other cardiovascular testing worldwide, as stated by the new market research report on Cholesterol and Other Cardiovascular Testing. Europe and the United States trail Asia-pacific in terms of unit sales for cholesterol and other cardiovascular tests. However, fastest growth is likely to emanate from the Japanese cholesterol and other cardiovascular testing market. The Japanese market is projected to register a CAGR of 6.7% over the analysis period. Lipid Panel Test/Complete Lipid Profile constitutes the largest as well as fastest growing segment in the global cholesterol and other cardiovascular tests market. HDL Cholesterol Test represents other major segment in terms of test volume. While, Apolipoprotein B is projected to be the second fastest growing market for cholesterol and other cardiovascular tests, with a CAGR of about 7.2% over the analysis period.

Although cholesterol testing is extensively being performed at physician offices or other healthcare centers, the scenario is rapidly changing towards home testing. A major noticeable trend is the emergence of home cholesterol test kits, which are available over the counter. Advances in technology, changing patient demographics as well as increasing managed care costs are propelling growth of home cholesterol testing. On the other hand, a vast potential of population remains untapped, thus promising significant growth opportunities for existing players, as well as new entrants. Overall, growth in the testing volumes is set to be more than proportionate to the growing number of people at risk of CVD, strongly influenced by new guidelines, publications, and awareness programs. Several new variants of cardiovascular and other tests such as homocysteine test, C-reactive protein test are seeing the light of the day, promising more clarity in CVD risk assessment.

Major players profiled in the report include AccuTech LLC, Alere Inc., Axis-Shield Plc, Biosite Inc., Cholestech Corporation, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd, Home Access Health Corporation, Polymer Technology Systems Inc., and Siemens Healthcare Diagnostics Inc.

The research report titled “Cholesterol and Other Cardiovascular Testing: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the cholesterol and other cardiovascular testing markets, current market trends, key growth drivers, an insight into cardiovascular diseases, cholesterol testing & CVD risk assessment techniques, cholesterol control & treatment modalities, recent product introductions, recent industry activity, and profiles of major/niche global as well as regional market participants. The report provides annual unit sales estimates and projections for Cholesterol and Other Cardiovascular Testing market for the years 2007 through 2015 for the following geographic markets - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Key segments analyzed include Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests. Also, a seven-year (2000-2006) historic analysis is provided for additional perspective.

For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Cholesterol_and_Other_Cardiovascular_Testing_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website

Media